Design smarter clinical trials. Discover novel biomarkers. Repurpose existing drugs or identify new therapies. Genedata Profiler® empowers your team to make data-informed, early go/no-go decisions.
Translational Research. Reversed.
Leverage the full collection of your discovery and preclinical data to select the compounds with the highest probability of success for clinical development.
De-silo your data from ongoing and completed clinical studies and use it to design successful clinical trials. Discover and validate predictive biomarkers of drug response, use molecular markers for early detection of adverse events, find the best combination therapy, and develop new therapies faster.
Data flow from research to the clinic and back again. Realize the promise of bedside-to-benchtop research.
If you focus on the innovation, expansion, and diversification of your research pipeline, gates in drug discovery, preclinical development, and in phase I or II provide decision points for important evaluations.
The best decisions are made with a holistic view of all the data. Whether you are exploring drug response, demonstrating drug activity, characterizing drug effect, or describing drug efficacy or safety, with Genedata Profiler you have all your data in one place, FAIR, and secure.
Make data-informed and early go/no-go decisions for successful clinical trials, which bring life-saving drugs to patients faster.
High-throughput technologies have revolutionized medical research. Are you running genomics or transcriptomics projects to detect mutations, chromosomal alterations, or global gene expression levels? Or are you investigating epigenetic changes such as DNA methylation or histone acetylation in your patient cohort?
Regardless of the technology you use to produce data—by NGS, IHC, microarrays, MS, or other omic approaches such as transcriptomics, epigenomics, proteomics, metabolomics, or microbiomics—we have you covered. Bring multi-omics and clinical data securely together to unlock actionable insights. Precision medicine at your fingertips.
We are pleased to have found a reliable partner who provided us with expert knowledge in big multi-omics data analysis to accelerate our search for precision biomarkers to prognosticate disease course and to guide early and effective personalized treatment decisions.
Andrés Hurtado-Lorenzo, Ph.D.
Senior Director of Translational Research
Crohn’s & Colitis Foundation
Working closely with Genedata, we have generated a digital biomarker research platform that will enable Merck scientists to better utilize clinical and translational data to generate innovative ideas for new biomarkers and drug targets.
Joern Peter Halle
Head of Immuno-oncology and External Innovation
As we expect our clinical and pre-clinical programs and pipeline to continue to grow, we look forward to utilizing Genedata Profiler and Genedata Managed IT Services to assist us in our mission to develop safe, targeted, effective therapeutics for cancer patients.
John de Kruif, Ph.D.
Chief Technology Officer